Navigation Links
Beckman Coulter Updates 2008 Outlook
Date:12/16/2008

ORANGE COUNTY, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, reaffirms 2008 outlook and provides preliminary 2009 financial outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Scott Garrett, chairman, president and chief executive officer, said, "Despite broader economic uncertainties, we remain confident about achieving 2008 outlook and committed to double-digit earnings growth in 2009. While no company is fully insulated from vulnerable and volatile world markets, we expect our stable installed base to yield solid growth of recurring revenue and an intensified focus on operating excellence to drive achievement of our EPS objectives."

2008 Outlook

The company estimates that, based on current exchange rates, full year 2008 revenue should increase by about 12%. Operating margins are anticipated to be on par with prior year results, between 11.5% and 12%. Non operating expense should be about $48 million. Therefore, earnings per share expectations remain in the $3.55 to $3.65 range, with a tax rate of 26 to 27%.

2009 Preliminary Outlook

Full year 2009 revenue is expected to grow approximately 5% on a constant currency basis, driven by a continued steady trend in recurring revenue growth. Recurring revenue, which accounts for nearly 80% of total revenue, is anticipated to continue to grow approximately 7% in constant currency. Cash instrument sales should be flat to slightly down against unusually high sales levels in 2008. The company has implemented a zero overhead growth policy to control expenses. The shift in mix t
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. Yu receives research funding from the Wallace H. Coulter Foundation
2. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
3. World Energy Outlook to be presented at Rice University Dec. 9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... total gene activity in organs relevant for coronary artery ... Institutet have identified a module of genes that is ... the atherosclerotic plaque. The findings, which are to be ... suggest that targeting the migration of white blood cells ...
(Date:12/4/2009)... accepted thinking about amyloids the fibrous protein deposits associated ... open up a potential new area for therapeutics. , It ... of proteins sometimes known as fibres - are inert, but ... can damage cells and cause disease. , But in ...
(Date:12/3/2009)... windows or solar panels that repels grime and dirt? ... New Tel Aviv University research, just published in ... at the nano-scale level that could make these futuristic ... Operating in the range of 100 nanometers (roughly one-billionth ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2New therapy targets for amyloid disease 2A window that washes itself? 2Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 58319 1Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 58319 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2AFOSRs basic research may lead to revolutionary new devices 10102 1AFOSRs basic research may lead to revolutionary new devices 10102 2
... A University of Michigan research team has found that introducing ... therapy helped generate bone around dental implants, according to a ... Therapy. , In a patient with a sizeable mouth wound, ... one---the patient also needs the bone structure to anchor the ...
... prevailing belief that the HIV epidemic in the UK can ... that HIV spread via at least six independent virus introductions ... issue of the Proceedings of the National Academy of Sciences, ... impact on the growth of the epidemic and that changes ...
... in the passing of genetic material from a parent ... by a team of Berkeley researchers. Their study may ... recognize and stay attached to microtubules, hollow fibers in ... the faithful segregation of chromosomes during cell division. , ...
Other Biology News:Gene therapy promising for growing tooth-supporting bone 2Gene therapy promising for growing tooth-supporting bone 3HIV-1 spread through six transmission lines in the UK 2HIV-1 spread through six transmission lines in the UK 3Key mechanism in genetic inheritance during cell division identified 2Key mechanism in genetic inheritance during cell division identified 3
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Drug Discovery Technologies - A Global ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery ... of every pharmaceutical company,s business strategy. There ...
(Date:12/2/2009)... Dec. 2 The world,s first concept demonstration ... to replace a petrochemically produced ingredient in the manufacture ... in Copenhagen, Denmark, this week. One tire will be ... area at the Copenhagen International Airport throughout December 21, ...
(Date:12/2/2009)... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the ... connection with its previously announced unit offering, the underwriters ... an additional 637,500 units. Each unit is comprised of ... purchase warrant, and was sold at a price of ...
(Date:12/2/2009)... Holding NV,the Netherlands based biotechnology company focusing on protein ... that it,has appointed Wim E.M. Mol, Ph.D. as new ... Mol will be responsible for all of Pepscans corporate ... company. He brings to,Pepscan more than 20 years of ...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Dutch Biotech Company Pepscan Appoints New CEO 2
... promising new technique has been developed that will ... imaging of new cells injected into the body, ... The new technique, which involves engineering antibody fragments ... cells of interest for PET imaging purposescould significantly ...
... The Ensign,Group, Inc. (Nasdaq: ENSG ), the parent ... services and assisted living,companies, announced today that its Board ... per share of Ensign common stock, payable,on or before ... June 30, 2008.,Ensign has been a dividend-paying company since ...
... Line, PARSIPPANY, N.J., June 16 ... on nephrology and endocrinology,announced today that it ... ROCALTROL is a vitamin D analog prescribed ... resultant,metabolic bone disease in patients with moderate ...
Other Biology Technology:New molecular imaging techniques may lead to advances in disease treatment 2The Ensign Group Declares Quarterly Dividend 2Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc. 2
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: